Mount Auburn Hospital, Cambridge, Massachusetts, and Harvard Medical School, Boston, MA, USA.
Royal Melbourne Hospital and School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tax097.
Analysis of a large cohort of business travelers will help clinicians focus on frequent and serious illnesses. We aimed to describe travel-related health problems in business travelers.
GeoSentinel Surveillance Network consists of 64 travel and tropical medicine clinics in 29 countries; descriptive analysis was performed on ill business travelers, defined as persons traveling for work, evaluated after international travel 1 January 1997 through 31 December 2014.
Among 12 203 business travelers seen 1997-2014 (14 045 eligible diagnoses), the majority (97%) were adults aged 20-64 years; most (74%) reported from Western Europe or North America; two-thirds were male. Most (86%) were outpatients. Fewer than half (45%) reported a pre-travel healthcare encounter. Frequent regions of exposure were sub-Saharan Africa (37%), Southeast Asia (15%) and South Central Asia (14%). The most frequent diagnoses were malaria (9%), acute unspecified diarrhea (8%), viral syndrome (6%), acute bacterial diarrhea (5%) and chronic diarrhea (4%). Species was reported for 973 (90%) of 1079 patients with malaria, predominantly Plasmodium falciparum acquired in sub-Saharan Africa. Of 584 (54%) with malaria chemoprophylaxis information, 92% took none or incomplete courses. Thirteen deaths were reported, over half of which were due to malaria; others succumbed to pneumonia, typhoid fever, rabies, melioidosis and pyogenic abscess.
Diarrheal illness was a major cause of morbidity. Malaria contributed substantial morbidity and mortality, particularly among business travelers to sub-Saharan Africa. Underuse or non-use of chemoprophylaxis contributed to malaria cases. Deaths in business travelers could be reduced by improving adherence to malaria chemoprophylaxis and targeted vaccination for vaccine-preventable diseases. Pre-travel advice is indicated for business travelers and is currently under-utilized and needs improvement.
分析大量商务旅行者的资料将有助于临床医生关注频繁且严重的疾病。本研究旨在描述商务旅行者的旅行相关健康问题。
GeoSentinel 监测网络由 29 个国家的 64 家旅行和热带医学诊所组成;对 1997 年 1 月 1 日至 2014 年 12 月 31 日期间因国际旅行接受评估的商务旅行者进行了描述性分析。
1997-2014 年间,共观察到 12203 名商务旅行者(14045 例符合条件的诊断),其中大多数(97%)为 20-64 岁的成年人;大多数(74%)来自西欧或北美;三分之二为男性。大多数(86%)为门诊患者。不到一半(45%)报告有旅行前医疗接触。常暴露于以下地区:撒哈拉以南非洲(37%)、东南亚(15%)和南亚次大陆(14%)。最常见的诊断是疟疾(9%)、急性未特指腹泻(8%)、病毒性综合征(6%)、急性细菌性腹泻(5%)和慢性腹泻(4%)。1079 例疟疾患者中有 973 例(90%)报告了疟原虫种类,主要为在撒哈拉以南非洲感染的恶性疟原虫。584 例(54%)有疟疾化学预防信息,其中 92%未服用或未全程服用。报告了 13 例死亡,其中一半以上是由疟疾引起的,其余的死于肺炎、伤寒、狂犬病、类鼻疽和化脓性脓肿。
腹泻性疾病是发病率的主要原因。疟疾是发病率和死亡率的主要原因,尤其是在前往撒哈拉以南非洲的商务旅行者中。抗疟药物预防的使用不足或不使用导致疟疾病例增加。通过提高对疟疾化学预防的依从性和针对疫苗可预防疾病的靶向疫苗接种,可降低商务旅行者的死亡率。目前旅行前咨询在商务旅行者中利用率低,需要改进。